Cargando…

Concurrent validity of provisional remission criteria for gout: a dual-energy CT study

BACKGROUND: Provisional gout remission criteria including five domains (serum urate, tophus, flares, pain due to gout, and patient global assessment) have been proposed. The aim of this study was to test the concurrent validity of the provisional gout remission criteria by comparing the criteria wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalbeth, Nicola, Frampton, Christopher, Fung, Maple, Baumgartner, Scott, Nicolaou, Savvas, Choi, Hyon K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588898/
https://www.ncbi.nlm.nih.gov/pubmed/31227018
http://dx.doi.org/10.1186/s13075-019-1941-8
_version_ 1783429301611266048
author Dalbeth, Nicola
Frampton, Christopher
Fung, Maple
Baumgartner, Scott
Nicolaou, Savvas
Choi, Hyon K.
author_facet Dalbeth, Nicola
Frampton, Christopher
Fung, Maple
Baumgartner, Scott
Nicolaou, Savvas
Choi, Hyon K.
author_sort Dalbeth, Nicola
collection PubMed
description BACKGROUND: Provisional gout remission criteria including five domains (serum urate, tophus, flares, pain due to gout, and patient global assessment) have been proposed. The aim of this study was to test the concurrent validity of the provisional gout remission criteria by comparing the criteria with dual-energy CT (DECT) findings. METHODS: Patients with gout on allopurinol ≥ 300 mg daily were prospectively recruited into a multicenter DECT study. Participants attended a standardized study visit which recorded gout flare frequency in the preceding 12 months, physical examination for tophus, serum urate, and patient questionnaires. DECT scans of both hands/wrists, feet/ankles/Achilles, and knees were analyzed by two DECT radiologists. The relationship between the DECT urate crystal volume and deposition with individual domains as well as the provisional remission criteria set was analyzed. RESULTS: The provisional remission criteria were fulfilled in 23 (15.1%) participants. DECT urate crystal deposition was observed less frequently in those fulfilling the provisional remission criteria (44%), compared with those not fulfilling the criteria (73.6%, odds ratio 0.28, P = 0.004). The median (range) DECT urate crystal volume was 0.00 (0.00–0.46) cm(3) for those fulfilling the remission criteria, compared with 0.08 (0.00–19.53) cm(3) for those not fulfilling the criteria (P = 0.002). In multivariate regression analysis, the serum urate and tophus domains were most strongly associated with DECT urate crystal deposition. CONCLUSIONS: In people with gout established on allopurinol, a state of remission as defined by the provisional remission criteria is associated with less DECT urate crystal deposition. While this study provides support for the validity of the provisional gout remission criteria, it also demonstrates that some crystal deposition may be present in people achieving these criteria. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-019-1941-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6588898
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65888982019-07-08 Concurrent validity of provisional remission criteria for gout: a dual-energy CT study Dalbeth, Nicola Frampton, Christopher Fung, Maple Baumgartner, Scott Nicolaou, Savvas Choi, Hyon K. Arthritis Res Ther Research Article BACKGROUND: Provisional gout remission criteria including five domains (serum urate, tophus, flares, pain due to gout, and patient global assessment) have been proposed. The aim of this study was to test the concurrent validity of the provisional gout remission criteria by comparing the criteria with dual-energy CT (DECT) findings. METHODS: Patients with gout on allopurinol ≥ 300 mg daily were prospectively recruited into a multicenter DECT study. Participants attended a standardized study visit which recorded gout flare frequency in the preceding 12 months, physical examination for tophus, serum urate, and patient questionnaires. DECT scans of both hands/wrists, feet/ankles/Achilles, and knees were analyzed by two DECT radiologists. The relationship between the DECT urate crystal volume and deposition with individual domains as well as the provisional remission criteria set was analyzed. RESULTS: The provisional remission criteria were fulfilled in 23 (15.1%) participants. DECT urate crystal deposition was observed less frequently in those fulfilling the provisional remission criteria (44%), compared with those not fulfilling the criteria (73.6%, odds ratio 0.28, P = 0.004). The median (range) DECT urate crystal volume was 0.00 (0.00–0.46) cm(3) for those fulfilling the remission criteria, compared with 0.08 (0.00–19.53) cm(3) for those not fulfilling the criteria (P = 0.002). In multivariate regression analysis, the serum urate and tophus domains were most strongly associated with DECT urate crystal deposition. CONCLUSIONS: In people with gout established on allopurinol, a state of remission as defined by the provisional remission criteria is associated with less DECT urate crystal deposition. While this study provides support for the validity of the provisional gout remission criteria, it also demonstrates that some crystal deposition may be present in people achieving these criteria. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-019-1941-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-21 2019 /pmc/articles/PMC6588898/ /pubmed/31227018 http://dx.doi.org/10.1186/s13075-019-1941-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Dalbeth, Nicola
Frampton, Christopher
Fung, Maple
Baumgartner, Scott
Nicolaou, Savvas
Choi, Hyon K.
Concurrent validity of provisional remission criteria for gout: a dual-energy CT study
title Concurrent validity of provisional remission criteria for gout: a dual-energy CT study
title_full Concurrent validity of provisional remission criteria for gout: a dual-energy CT study
title_fullStr Concurrent validity of provisional remission criteria for gout: a dual-energy CT study
title_full_unstemmed Concurrent validity of provisional remission criteria for gout: a dual-energy CT study
title_short Concurrent validity of provisional remission criteria for gout: a dual-energy CT study
title_sort concurrent validity of provisional remission criteria for gout: a dual-energy ct study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588898/
https://www.ncbi.nlm.nih.gov/pubmed/31227018
http://dx.doi.org/10.1186/s13075-019-1941-8
work_keys_str_mv AT dalbethnicola concurrentvalidityofprovisionalremissioncriteriaforgoutadualenergyctstudy
AT framptonchristopher concurrentvalidityofprovisionalremissioncriteriaforgoutadualenergyctstudy
AT fungmaple concurrentvalidityofprovisionalremissioncriteriaforgoutadualenergyctstudy
AT baumgartnerscott concurrentvalidityofprovisionalremissioncriteriaforgoutadualenergyctstudy
AT nicolaousavvas concurrentvalidityofprovisionalremissioncriteriaforgoutadualenergyctstudy
AT choihyonk concurrentvalidityofprovisionalremissioncriteriaforgoutadualenergyctstudy